Circulating Biomarkers for Early Diagnosis of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, which is also often fatal. An early and accurate diagnosis is a decisive step towards the survival of the patients. Molecular biology improved significantly the prognosis of liver cancers through learned use of tumor markers...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/77115 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Circulating Biomarkers for Early Diagnosis of Hepatocellular Carcinoma
- Role of Biomarkers in Hepatocellular Carcinoma and Their Disease Progression
- Hepatocellular Carcinoma: Diagnosis and Surveillance
- Hepatocellular Carcinoma: Methods of Circulating Tumor Cells (CTC) Measurements
- The Histomorphological and Immunohistochemical Diagnosis of Hepatocellular Carcinoma
- New Molecular Biomarkers Candidates for the Development of Multiparametric Platforms for Hepatocellular Carcinoma Diagnosis, Prognosis and Personalised Therapy
- Differential Diagnosis of Hepatocellular Carcinoma on Computed Tomography